Gifu University · University Hospital

Research keywordsnon-Hodgkin lymphoma・peripheral T-cell lymphoma・rituximab regimens・salvage chemotherapy・graft-versus-host disease・geriatric assessment・acute promyelocytic leukemia・acquired hemophilia

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• ATO投与中に心嚢液貯留を認めたAPLの1例
• Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High-Dose Cytarabine-Based Chemotherapy as Second-Line Treatments for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
• [Acquired hemophilia A complicated by dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid].
• Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study.

• Official profile